asa guidelines on glp-1 New therapeutic agents for type 2 diabetes: anaesthetic considerations. A narrative review Glucagon‐like peptide‐1 receptor agonists: a

Protein matters on GLP-1 medications, but vitamins, minerals, and fiber matter too

When my GP told me I was pre-diabetic, it was a real wake-up call

Corxel Pharmaceuticals raises $287M Series D1 with new investors SR One, TCGX & RA Capital to advance oral GLP-1 program acquired from Vincentage & other pipeline assets.

Sort of like looking for the shape of a keyhole into which a given key would fit

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.

The heatmap below illustrates how side effects differ across GLP-1 drugs, offering a snapshot of how people experience their GLP-1 medication in everyday life